Operational Definition of Liver Cancer in Studies Using Data from the National Health Insurance Service: A Systematic Review.

IF 2.5 Q3 ONCOLOGY Journal of Cancer Prevention Pub Date : 2023-06-30 DOI:10.15430/JCP.2023.28.2.47
Yu Rim Kim, Ji Yoon Baek, Seung Hee Seo, Hyeree Park, Sooyoung Cho, Aesun Shin, Sup, Sup
{"title":"Operational Definition of Liver Cancer in Studies Using Data from the National Health Insurance Service: A Systematic Review.","authors":"Yu Rim Kim,&nbsp;Ji Yoon Baek,&nbsp;Seung Hee Seo,&nbsp;Hyeree Park,&nbsp;Sooyoung Cho,&nbsp;Aesun Shin,&nbsp;Sup,&nbsp;Sup","doi":"10.15430/JCP.2023.28.2.47","DOIUrl":null,"url":null,"abstract":"<p><p>Data from the Korean National Health Insurance Service (NHIS) have been widely used to provide real-world evidence. Due to the nature of claims data, researchers use operational definitions to define patients with specific diseases. This study aimed to conduct a systematic review of the operational definitions of liver cancer used in studies based on the NHIS database and to suggest the most appropriate operational definition. Literature search was completed on January 6, 2021, using PubMed and KoreaMed. We applied the most frequently used operational definitions of liver cancer to the NHIS-National Sample Cohort and calculated age-standardized incidence rates (ASRs) of liver cancer by year. The ASRs using each operational definition were compared with the ASR from the Korea Central Cancer (KCCR) data. Among 236 articles, 90 were selected for review, covering histologically various kinds of liver cancer and varied by study subjects. Most studies (n = 79) did not mention whether the codes for the operational definition were from only the main diagnosis or from both the main and sub-diagnosis. The most frequently used operational definition was C22 (n = 39); however, the most similar operational definition was the ASR using \"C22.0 or C22.9\" for men and \"C22.0\" for women as the main diagnosis to the ASR from the KCCR. Based on the comparison with KCCR data, we suggest using \"C22.0 or C22.9\" for men and \"C22.0\" for women as the main diagnosis for the operational definition of liver cancer when using the NHIS data.</p>","PeriodicalId":15120,"journal":{"name":"Journal of Cancer Prevention","volume":"28 2","pages":"47-52"},"PeriodicalIF":2.5000,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331033/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15430/JCP.2023.28.2.47","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Data from the Korean National Health Insurance Service (NHIS) have been widely used to provide real-world evidence. Due to the nature of claims data, researchers use operational definitions to define patients with specific diseases. This study aimed to conduct a systematic review of the operational definitions of liver cancer used in studies based on the NHIS database and to suggest the most appropriate operational definition. Literature search was completed on January 6, 2021, using PubMed and KoreaMed. We applied the most frequently used operational definitions of liver cancer to the NHIS-National Sample Cohort and calculated age-standardized incidence rates (ASRs) of liver cancer by year. The ASRs using each operational definition were compared with the ASR from the Korea Central Cancer (KCCR) data. Among 236 articles, 90 were selected for review, covering histologically various kinds of liver cancer and varied by study subjects. Most studies (n = 79) did not mention whether the codes for the operational definition were from only the main diagnosis or from both the main and sub-diagnosis. The most frequently used operational definition was C22 (n = 39); however, the most similar operational definition was the ASR using "C22.0 or C22.9" for men and "C22.0" for women as the main diagnosis to the ASR from the KCCR. Based on the comparison with KCCR data, we suggest using "C22.0 or C22.9" for men and "C22.0" for women as the main diagnosis for the operational definition of liver cancer when using the NHIS data.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用国民健康保险服务数据的研究中肝癌的操作定义:系统回顾。
来自韩国国民健康保险公社(NHIS)的数据已被广泛用于提供真实世界的证据。由于索赔数据的性质,研究人员使用操作定义来定义患有特定疾病的患者。本研究旨在对基于NHIS数据库的研究中使用的肝癌的手术定义进行系统回顾,并提出最合适的手术定义。文献检索于2021年1月6日通过PubMed和KoreaMed完成。我们将最常用的肝癌操作定义应用于NHIS-National样本队列,并按年计算肝癌的年龄标准化发病率(ASRs)。将使用每种操作定义的ASR与来自韩国中心癌症(KCCR)数据的ASR进行比较。在236篇文献中,选取90篇文献进行综述,涵盖组织学上不同类型的肝癌,且因研究对象而异。大多数研究(n = 79)没有提及操作定义的代码是仅来自主要诊断还是来自主要诊断和次级诊断。最常用的操作定义是C22 (n = 39);然而,最相似的操作定义是ASR,男性使用“C22.0或C22.9”,女性使用“C22.0”作为KCCR对ASR的主要诊断。通过与KCCR数据的比较,我们建议在使用NHIS数据时,男性使用“C22.0或C22.9”,女性使用“C22.0”作为肝癌手术定义的主要诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
4.00%
发文量
32
期刊最新文献
Anticancer Activity of Phytochemicals of the Papaya Plant Assessed: A Narrative Review. Kaempferol Synergistically Enhances Cisplatin-induced Apoptosis and Cell Cycle Arrest in Colon Cancer Cells. Recommendations for Healthy Lifestyle for Cancer Prevention and Healthy Aging. Elevated N1-Acetylspermidine Levels in Doxorubicin-treated MCF-7 Cancer Cells: Histone Deacetylase 10 Inhibition with an N1-Acetylspermidine Mimetic. Ribosomal Protein L9 Maintains Stemness of Colorectal Cancer via an ID-1 Dependent Mechanism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1